Douglas Pharma builds a data-driven future with Kneat Gx

Douglas Pharmaceuticals' paper-based validation caused approval delays, audit risk, visibility gaps, lost documents, and inconsistent reporting. It implemented Kneat Gx, chosen for its user-friendly interface, flexibility and 98% requirements match, focusing on Computer System Validation (CSV) with implementation partner No Deviation for a rapid, smooth rollout. Outcomes: 24/7 validation visibility, 98% of user requirements met, faster approvals with remote sign-off, easier document retrieval for auditors, and better reviewer efficiency. Application Solution Manager Paul Campbell said: 'Now the system is in demand. Everyone wants in -- because they've seen Kneat in action.'

Kneat is a paperless computer-system and process-validation platform — one of the two dominant players in digitizing the validation evidence GxP systems require before go-live.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.